You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Sarepta
since
auto-detected in 6 stories
7 months ago
These are some of the stocks posting the largest moves in the premarket.
It's a high-risk trade, but this biotech down 80% this year could be a buy ○
Jay Woods breaks down the charts on Sarepta.
10 months ago
Stocks making the biggest moves midday: Carrier, Johnson Controls, Chart Industries, Sarepta ○
These are some of the stocks posting the largest moves midday.
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk ○
Sarepta is facing intense scrutiny following the death of two non-ambulatory teenage boys associated with Elevidys.
Sarepta to pause gene therapy Elevidys shipments in U.S. ○
Sarepta Therapeutics said on Monday that it will pause all shipments of its Elevidys gene therapy in the United States after a muscular dystrophy patient who received a different, experimental treatm…
Sarepta shares plunge 40% as future of its gene therapy appears at risk ○
Sarepta reported a third death tied to its gene therapies.
page 1 of 1